Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

A healthcare media agency wanted to increase awareness of their brand with additional direct to consumer (DTC), HIPAA and NAI compliant, privacy safe audiences. They wanted to drive prescriptions for consumers with migraines. The audiences needed to be applicable across channels and activatable on their preferred demand side platform (DSP).

A healthcare media agency wanted to increase awareness of their brand with additional direct to consumer (DTC), HIPAA and NAI compliant, privacy safe audiences. They wanted to drive prescriptions for consumers with migraines. The audiences needed to be applicable across channels and activatable on their preferred demand side platform (DSP).

Learn more about what PurpleLab can do for Clinical Trials Life Sciences Download

As the pharmaceutical and healthcare media industries face unprecedented change, the Preparing for 2025 roundtable convened leading experts to chart a path forward. Against a backdrop of rising patient expectations, accelerating technological advancements, and increasing regulatory pressures, this collaborative forum sought to address critical challenges while uncovering collective alignment for sustainable success.

PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  NBC News Biden proposes weight loss drug coverage for people on Medicare and Medicaid Read Now 11/26/2024 Pharma Exec Balancing Personalized Targeting with Protecting Consumer Privacy Read Now 11/5/2024 Pharma Exec Promising Alternative Targeting…

PurpleLab® took part in HLTH 24’s Payer Insights Session on October 20th, 2024. Led by Med City New’s Arundhati Pramar, we were joined on stage by Humana’s Pankhuri Sharma and Managed Care Resource Alliance’s Darren E. Wethers for an insightful discussion on how payers can leverage claims data insights to link reimbursements and preventive care. We invite…

We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience.

The value of real-world data (RWD) and real-world evidence (RWE) for pharmaceutical companies goes far beyond clinical and drug development applications, such as clinical trial feasibility studies, manufacturing, health economic and outcomes research and medical affairs. These datasets are also recognized as critical tools for shaping effective marketing and commercial strategies. The importance of real-world…

PurpleLab®, a leading healthcare analytics company with one of the largest medical and pharmaceutical claims databases in the US, is pleased to announce its membership in the Network Advertising Initiative (NAI), the leading self-regulatory organization dedicated to responsible data collection and use in digital advertising. In joining the NAI, PurpleLab strengthens its commitment to maintaining…